Infection Risk Prediction After Transplant
Part of Infections clinical trials.
This study is for people who have had a stem cell or solid organ transplant. It aims to predict who might get a serious infection and help doctors manage their care better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have received a stem cell transplant (from a donor) or a solid organ transplant (like kidney, heart, or lung).
- You are an adult or a child.
- You or your legal guardian can sign a form to agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people who have had a recent organ or stem cell transplant to learn more about infections and how they can be prevented. You may be asked to provide samples and information over time.
This study looks at how well vaccines work in people who have received a bone marrow or solid organ transplant. Researchers will track infections and outcomes to understand vaccine effectiveness.
This study is following people who have had a liver, kidney, heart, or lung transplant. It will look for markers in your blood that might help predict how you do in the short and long term after transplant.
This study uses a special score (immune risk score) to check how well your immune system rebuilds after a half-matched stem cell transplant. The goal is to find patients who might need extra help with immune recovery.
This study develops a score to predict infection risk right after a liver transplant. It uses blood samples from transplant day to identify which patients are more likely to get infections, helping doctors tailor care.
This study looks at how well patients are informed about the risk of infections after a lung or heart-lung transplant. It aims to improve the information given to future patients.
Hear when a new Immunocompromised Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.